Palacín-Aliana, I.; García-Romero, N.; Asensi-Puig, A.; Carrión-Navarro, J.; González-Rumayor, V.; Ayuso-Sacido, Á.
Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR. Biomedicines 2021, 9, 906.
https://doi.org/10.3390/biomedicines9080906
AMA Style
Palacín-Aliana I, García-Romero N, Asensi-Puig A, Carrión-Navarro J, González-Rumayor V, Ayuso-Sacido Á.
Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR. Biomedicines. 2021; 9(8):906.
https://doi.org/10.3390/biomedicines9080906
Chicago/Turabian Style
Palacín-Aliana, Irina, Noemí García-Romero, Adrià Asensi-Puig, Josefa Carrión-Navarro, Víctor González-Rumayor, and Ángel Ayuso-Sacido.
2021. "Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR" Biomedicines 9, no. 8: 906.
https://doi.org/10.3390/biomedicines9080906
APA Style
Palacín-Aliana, I., García-Romero, N., Asensi-Puig, A., Carrión-Navarro, J., González-Rumayor, V., & Ayuso-Sacido, Á.
(2021). Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR. Biomedicines, 9(8), 906.
https://doi.org/10.3390/biomedicines9080906